lacidipine Tablets, film coated 2 mg, 4 mg, 6 mg

Dossier type
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
Unavailable markets
Vietnam , Poland
Available for
Licensing with supply, Distribution only
Manufacturer #11864
A pharmaceutical manufacturer based in the EU that is active in 20+ countries worldwide selling its products in EU, CIS, LATAM, and South-East Asia for 30+ years. Key production lines are Rx medicines, OTC drugs, and dietary supplements with EU GMP certification. The company's main therapeutic areas include oncology, cardiology, psychiatry, and internal medicine. The company provides eCTD format dossiers as well as BE studies and stability studies.

Manufacturer usually replies in 7 days

Lacidipine Manufacturers

Markets of interest

Lacidipine is an antihypertensive agent which is prescribed to dilate peripheral arterioles and reduce blood pressure. The substance exhibits a greater antioxidant activity which may confer potentially beneficial antiatherosclerotic effects. Due to its long duration of action, this drug does not lead to reflex tachycardia. The substance is available for sale in the form of tablets, film-coated tablets, from manufacturers in various countries including Y. The drug is provided by a wide range of Lacidipine suppliers from various countries including the Y, Y, and Y. Mostly due to the availability of raw materials for the manufacturing process and low labor costs, the leading Lacidipine manufacturers and distributors are based in China.

Licensing and brand names

Lacidipine was approved for medical use in 1991. The medication is presently approved in many countries and is available in both generic and trade name versions. The medication is marketed under the trade names including Lacipil, Motens, Lacivas, Sinopil, Sinopril. One of the most popular branded versions of Lacidipine is manufactured and supplied by the Spanish pharmaceutical company LEBSA. Other manufacturing companies and distributors from European Union, Switzerland, Taiwan, Japan. have also successfully adapted to the demands of the global marketplace and produce a variant of the drug with Lacidipine as an active ingredient.

Target supply price

The wholesale acquisition cost of Lacidipine depending on the drug concentration in one tablet and pack’s size ranges from $79 to $90. In Europe, the retail price of the film-coated tablets that contain 4mg of the substance per tablet reaches 17.94EUR per pack. The medication wholesale prices and commercial terms can vary depending on the supplier. The medication wholesale prices and commercial terms can vary depending on the supplier.

Information from manufacturers

We provide a detailed list of the Lacidipine manufacturers and suppliers that you are looking for. You can also find the dossier status of Lacipidine and the GMP approvals of the different variants of the medication. The product description of all Lacipidine suppliers contains essential information about the medication you order including clinical data, stability zones, and a list of countries where Lacipidine is already registered in. Manufacturers also specify the commercial terms of their offers, such as the market for which the offer is intended, deal type, dossier licensing fee, supply price, payment terms as well as delivery terms. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified Follicle-stimulating hormone suppliers and distributors enter our online marketplace, offering you a risk-free global B2B pharmaceutical sales platform.